Expansion of CD16 positive and negative human NK cells in response to tumor stimulation

Pinchas Tsukerman, Noam Stern-Ginossar, Rachel Yamin, Yael Ophir, Anna Miller Noa Stanietsky, Ofer Mandelboim*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


NK cells are innate immune lymphocytes that express a vast repertoire of germ-line encoded receptors for target recognition. These receptors include inhibitory and activating proteins, among the latter of which is CD16, a low affinity binding Fc receptor. Here, we show that human NK cells expand in response to stimulation with various tumor cell lines. We further demonstrate that the tumor-derived expansion of NK cells is accompanied by rapid, cell-dependent, changes in CD16 expression levels. We show that in NK cells expanded in response to the EBV-transformed cell line 721.221, CD16 is shed and therefore approximately half of the expanded 721.221-derived NK-cell population does not express CD16. We also show, in contrast, that in response to 1106mel cells, CD16 expression is maintained on the cell surface of the expanded NK cells due to an antibody-dependent mechanism. Our results may provide a basis for the selective expansion of NK cells that may be used for tumor immunotherapy.

Original languageAmerican English
Pages (from-to)1517-1525
Number of pages9
JournalEuropean Journal of Immunology
Issue number5
StatePublished - May 2014


  • Antibodies
  • CD16
  • Human NK cells
  • NK-cell-expansion


Dive into the research topics of 'Expansion of CD16 positive and negative human NK cells in response to tumor stimulation'. Together they form a unique fingerprint.

Cite this